Just to clarify for others, Becky, in the HERA trial and adjuvant Herceptin NCI trials, the hormonal receptors
were separated out. It was found that Her2+ women who are also hormone positive relapse less in the first few years compared to hormonal negatives. However, it was not clear, because the data is not available yet, if these women will acutally relapse later than sooner. It is too soon to
fully comment on the hormonal positive, her2 combination long term relapse history, beyond five years, unitl the long term data from the HERA trial is revealed.
http://content.nejm.org/cgi/data/353/16/1673/DC1/1
Just to add, from the above link, the relapse data for hormonal negatives and postives that are her2+ also are grapphed out in the lower last panels for five years out.